These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3165155)

  • 21. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature.
    Peters WG; Willemze R; Colly LP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):86-91. PubMed ID: 3473687
    [No Abstract]   [Full Text] [Related]  

  • 23. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
    Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
    Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
    [No Abstract]   [Full Text] [Related]  

  • 25. Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy.
    Rivera G; George SL; Bowman WP; Kalwinsky D; Ochs J; Dahl GV; Hustu HO; Simone JV
    J Clin Oncol; 1983 Aug; 1(8):471-6. PubMed ID: 6583322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pullen J; Boyett J; Shuster J; Crist W; Land V; Frankel L; Iyer R; Backstrom L; van Eys J; Harris M
    J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of two cases on the same day of intrathecal methotrexate overdose using cerebrospinal fluid exchange and intrathecal instillation of carboxypeptidase-G2.
    Wormdal OM; Flægstad T; Stokland T
    Pediatr Hematol Oncol; 2018; 35(5-6):350-354. PubMed ID: 30672361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
    Sullivan MP; Brecher M; Ramirez I; Ragab A; Hvizdala E; Pullen J; Shuster J; Berard C; Crist W; Vietti T
    Am J Pediatr Hematol Oncol; 1991; 13(3):288-95. PubMed ID: 1793154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
    Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
    Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 33. [Case report of meningeal carcinomatosis of gastric cancer successfully treated with intrathecal and systemic chemotherapy].
    Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Takano Y; Takagi K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):155-9. PubMed ID: 3917654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia.
    Lauer SJ; Pinkel D; Buchanan GR; Sartain P; Cornet JM; Krance R; Borella LD; Casper JT; Kun LE; Hoffman RG
    Cancer; 1987 Nov; 60(10):2366-71. PubMed ID: 3499211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia.
    Ozön A; Topaloğlu H; Cila A; Günay M; Cetin M
    Brain Dev; 1994; 16(3):246-8. PubMed ID: 7943613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
    Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of acute lymphoblastic leukemia in adults using the 08 LA 74 and RALL 81 A protocols].
    Colović M; Petrović M; Janković G; Janosević S; Jancić M
    Srp Arh Celok Lek; 1988 Mar; 116(3):227-33. PubMed ID: 3166210
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin.
    Ishii E; Hara T; Ohkubo K; Matsuzaki A; Takeuchi T; Ueda K
    Med Pediatr Oncol; 1986; 14(2):73-7. PubMed ID: 3458999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.
    González-Barca E; Canales M; Salar A; Ferreiro-Martínez JJ; Ferrer-Bordes S; García-Marco JA; Sánchez-Blanco JJ; García-Frade J; Peñalver J; Bello-López JL; Sancho JM; Caballero D;
    Ann Hematol; 2016 May; 95(6):893-9. PubMed ID: 27025508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.